HRSA-25-010: Rural Communities Opioid Response Program-Overdose Response
Closed
This grant is closed. A newer notice from the same program is forecast: Rural Communities Opioid Response Program - Overdose Response (HRSA-27-040). Status: Expected deadline March 10, 2027. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants of up to $300,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 20 awards worth $6.0 million in total. Applications closed on March 10, 2025.
From the official notice on Grants.gov, last changed December 20, 2024. Checked November 7, 2026.
- Award ceiling$300,000
- Total funding$6.0 million
- Expected awards20
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-27-040 | August 21, 2026 | Expected deadline March 10, 2027 | Forecast |
| HRSA-23-038 | October 21, 2022 | Closed January 19, 2023 | Closed |
Key dates
| Posted | December 20, 2024 |
|---|---|
| Deadline | March 10, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
These types of domestic* organizations may apply: Public institutions of higher education Private institutions of higher education Non-profits with or without a 501(c)(3) IRS status For-profit organizations, including small businesses State, county, city, township, and special district governments, including the District of Columbia, domestic territories, and freely associated states Independent school districts Native American tribal governments Native American tribal organizations * Domestic means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Individuals are not eligible applicants under this NOFO.
Is this a realistic fit?
- Past Rural Healthcare Services Programs awards averaged $487,643; this notice allows up to $300,000 per award.
- No cost sharing or match is required.
What the grant funds
The purpose of RCORP – Overdose Response is to support improving health care in rural areas by addressing their immediate and short-term needs related to the provision of substance use disorder services. RCORP – Overdose Response aims to reduce and prevent the risk of overdoses in rural areas.
Who has won Rural Healthcare Services Programs grants before
From fiscal 2021 to 2025, Rural Healthcare Services Programs (93.912) awarded $727 million across 1,490 grant awards, an average of $487,643 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Rural Health Resource Center | Minnesota | 3 | $58.6 million |
| University of North Dakota | North Dakota | 3 | $10.3 million |
| JBS International, Inc. | Maryland | 1 | $10.1 million |
| Arkansas Rural Health Partnership | Arkansas | 6 | $8.3 million |
| Rural Health Redesign Center Organization, Inc. | Pennsylvania | 3 | $7.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-040, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-25-010 still open?
No. It closed on March 10, 2025. A newer notice is forecast: HRSA-27-040, expected deadline March 10, 2027.
Who can apply for Rural Communities Opioid Response Program-Overdose Response?
Health Resources and Services Administration accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Communities Opioid Response Program-Overdose Response?
Closed March 10, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $300,000 each. About $6.0 million in total across about 20 awards.
Who has won Rural Healthcare Services Programs grants before?
The largest recipients over five fiscal years were Rural Health Resource Center, University of North Dakota, JBS International, Inc. The program made 1,490 awards worth $727 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)